Skip to content

Open labeled,active Controlled,randomized,prospective evaluation of vasadi Guggulu in the managment of Urdhvag Amlapitta (Hyperacidity).

Open labeled,active Controlled,randomized,prospective evaluation of vasadi Guggulu in the managment of Urdhvag Amalapitta.

Status
Active, not recruiting
Phases
Phase 1Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/03/024365
Enrollment
35
Registered
2020-03-30
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K00-K95- Diseases of the digestive system

Interventions

Intervention1: Vasadi Guggulu: Vasadi Guggulu Is Prepared As Per Ayurved Text.Dose-250 mg,Frequency-twice a day before meal,Duration-30 Days,Route- oral. Control Intervention1: Ranitidine: Dose-150 mg

Sponsors

CARC Nigdi Pune
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients having signs and symptoms of Urdhvag Amlapitta described in Madhava Nidana minimum since past 1 month 1)Chardi (Vomiting) 2)Amlodgar (Flatulence) 3)Hrullas (nausea) 4)Hruda-kanthadaha(Burnning sensation in chest-throat) 5)Udardaha (Burning sensation in stomach ) 6)Shirashool (headache) 7)Hastapada daha 8)Aruchi(Loss of appetite) 9)Mandalotpati( urticaril rash)

Exclusion criteria

Exclusion criteria: .Patients having signs and symptoms of Urdhvag Amlapitta described in Madhava Nidana minimum since past 1 month 1)Chardi (Vomiting) 2)Amlodgar (Flatulence) 3)Hrullas (nausea) 4)Hruda-kanthadaha(Burnning sensation in chest-throat) 5)Udardaha (Burning sensation in stomach ) 6)Shirashool (headache) 7)Hastapada daha 8)Aruchi(Loss of appetite) 9)Mandalotpati( urticaril rash)

Design outcomes

Primary

MeasureTime frame
To compare the efficacy of Vasadi Guggulu and Ranitidine in the management of Urdhvag Amlapitta.Timepoint: 30 Days with Follow up After 7 Days

Secondary

MeasureTime frame
To Study The Side Effects of Drug If AnyTimepoint: 30 Days

Countries

India

Contacts

Public ContactDr Rahul Arun Ghaste

PDEAs College of Ayurveda And Research Centre Akurdi Pune

medhamaheshjoshi@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026